Jefferies Group LLC Viatris Inc Call Options Transaction History

Jefferies Group LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 15, 2022	SELL	$9.95 - $12.27 $696,500 - $858,900	-70,000 Closed	0 $0
Q1 2022 Sep 21, 2023	BUY	$9.81 - $15.4 $224,649 - $352,660	22,900 Added 48.62%	70,000 $761,000
Q1 2022 May 16, 2022	BUY	$9.81 - $15.4 $224,649 - $352,660	22,900 Added 48.62%	70,000 $762,000
Q1 2021 Sep 21, 2023	SELL	$13.59 - $18.54 $48.4 Million - $66.1 Million	-3,563,100 Reduced 98.7%	47,100 $657,000
Q1 2021 May 14, 2021	SELL	$13.59 - $18.54 $48.4 Million - $66.1 Million	-3,563,100 Reduced 98.7%	47,100 $658,000
Q4 2020 Sep 21, 2023	BUY	$14.3 - $18.74 $51.6 Million - $67.7 Million	3,610,200 New	3,610,200 $67.7 Million
Q4 2020 Feb 16, 2021	BUY	$14.3 - $18.74 $51.6 Million - $67.7 Million	3,610,200 New	3,610,200 $67.7 Million

1,102

934M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.8B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.